These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 18338663

  • 1. Correlation between NT-proBNP values and changes in functional capacity in patients with chronic heart failure.
    Fernandes R, Feliciano J, Soares RM, Mamede A, Ramos R, Miranda F, Silva S, Timóteo AT, Abreu A, Ferreira R.
    Rev Port Cardiol; 2007 Dec; 26(12):1329-44. PubMed ID: 18338663
    [Abstract] [Full Text] [Related]

  • 2. NT-proBNP values and Weber functional class in patients with chronic heart failure.
    Fernandes R, Feliciano J, Soares RM, Mamede A, Ramos R, Silva S, Serra J, Oliveira JA, Abreu J, Abreu A, Ferreira R.
    Rev Port Cardiol; 2007 Dec; 26(12):1311-24. PubMed ID: 18338662
    [Abstract] [Full Text] [Related]

  • 3. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Dec; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 4. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure?
    Meyer T, Schwaab B, Görge G, Scharhag J, Herrmann M, Kindermann W.
    Z Kardiol; 2004 Jul 23; 93(7):540-5. PubMed ID: 15243765
    [Abstract] [Full Text] [Related]

  • 7. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, Possemiers N, Wuyts FL, Vrints CJ.
    Eur Heart J; 2004 Oct 23; 25(20):1797-805. PubMed ID: 15474694
    [Abstract] [Full Text] [Related]

  • 8. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL, Qiu YR, Zhou F, Feng PF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 23; 28(5):866-9. PubMed ID: 18504223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M.
    Rom J Intern Med; 2009 May 23; 47(1):35-40. PubMed ID: 19886067
    [Abstract] [Full Text] [Related]

  • 11. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN, Piechota WT, Bejm J, Wierzbowski R, Michałkiewicz D.
    Adv Med Sci; 2006 May 23; 51():164-7. PubMed ID: 17357300
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 13; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.
    Eur J Cardiovasc Prev Rehabil; 2008 Feb 13; 15(1):113-8. PubMed ID: 18277196
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L, Brito D, Matias JS, Madeira H.
    Rev Port Cardiol; 2007 Feb 13; 26(7-8):717-26. PubMed ID: 17939581
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN, Val-HeFT Investigators.
    J Am Coll Cardiol; 2008 Sep 16; 52(12):997-1003. PubMed ID: 18786480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.